[Voice disorders associated with novel coronavirus infection].

M A Krishtopova T L Alenskaya M K Azaronak L V Petrova

Published in: Vestnik otorinolaringologii (2024)

In patients with dysphonia or aphonia associated with COVID-19 are indicated a refractory type of dysphonia. This was indicated by the study of AEPs of the brain. The clinical algorithm for treatment and diagnostic patients with voice disorders after COVID-19 has been developed. The treatment of this group of patients should be adjunct by the drug therapy, kinesiotaping method and psychotherapy.

Keyphrases

coronavirus disease
sars cov
machine learning
newly diagnosed
emergency department
stem cells
combination therapy
mesenchymal stem cells
replacement therapy
blood brain barrier
resting state
electronic health record
neural network
chemotherapy induced